McAvoy David R. 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 5, 2024
Insider Transaction Report
Form 4
McAvoy David R.
EVP, Chief Legal Officer
Transactions
- Award
Restricted Share Units
2024-03-04+66,964→ 66,964 total→ Ordinary Shares (66,964 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on March 4, 2024, with 16,741 vesting on each of March 4, 2025, March 4, 2026, March 4, 2027 and March 4, 2028.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.